Unfortunately, the failure of success in PD phase 3 clinical trials continues. SURE-PD3, a phase 3 trial researching Inosine's ability to slow PD progression, has been halted early. Based on the study's DSMB's review of interim data, the board determined that the results would not be able to show that inosine can slow progression.

Another one bites the dust.....

Parkinson's Inosine Trial Ending Early | Parkinson's Disease